RxDoctor Payments DataLook up a doctor →

Gaurav Kumar, MD

Pulmonary Disease · Portage, INNPI 1225219462

Payments from drug & device makers

$102,060in general payments, 2019–2025

Across 914 payments — averaging $111.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$83K
  • Johnson & Johnson$2K
  • Boehringer Ingelheim$1K
  • Bayer$1K
  • Actelion Pharmaceuticals US, Inc.$1K
  • Novo Nordisk$1K
  • plus $12K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AstraZeneca(2 entities)160$82,555
Johnson & Johnson(2 entities)49$1,975
Boehringer Ingelheim73$1,438
Bayer49$1,274
Actelion Pharmaceuticals US, Inc.29$1,099
Novo Nordisk53$1,095
AbbVie(2 entities)35$998
GSK75$933
Sanofi28$635
Mylan Specialty L.p.34$565
Pulmonx Corporation7$546
Sanofi-aventis U.S. LLC11$535
Fresenius USA Marketing, Inc.1$500
Regeneron Healthcare Solutions, Inc.25$457
Pfizer25$400
Esperion Therapeutics, Inc.15$399
Merck16$345
Veran Medical Technologies, Inc.4$343
Sunovion Pharmaceuticals Inc.22$331
Takeda Pharmaceuticals U.S.A., Inc.15$327
United Therapeutics Corporation6$324
Abbott2$300
Amarin Pharma, Inc.8$287
Insmed, Inc.8$286
Shionogi Inc10$255
Amgen(2 entities)5$212
Baxter Healthcare9$201
ANI Pharmaceuticals, Inc.7$184
Electromed, Inc.20$182
Biohaven Pharmaceutical Holding Company Ltd.2$180
EKOS Corporation2$168
Lilly USA, LLC11$168
Grifols USA, LLC9$158
Genentech USA, Inc.2$138
Intuitive Surgical5$133
Novartis2$132
Philips North America LLC8$129
Boston Scientific1$125
Lexicon Pharmaceuticals, Inc.1$123
Jazz Pharmaceuticals Inc.9$114
Otsuka America Pharmaceutical, Inc.5$103
Ceribell, Inc.2$102
Dexcom, Inc.7$100
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC1$100
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)1$100
Chiesi USA, Inc.6$97
Insulet Corporation2$94
Inspire Medical Systems, Inc.3$89
Itamar Medical Inc2$80
Axsome Therapeutics, Inc.1$59
Advanced Respiratory, Inc3$55
Inogen, Inc.4$53
IBSA Pharma Inc.3$53
Teva Pharmaceuticals USA, Inc.2$43
Eisai Inc.2$40
Paratek Pharmaceuticals, Inc.2$38
Exact Sciences1$31
Gilead1$27
Mayne Pharma Commercial LLC1$27
Adlon Therapeutics L.p.1$24

How this compares

$102,060 in reported general payments places this provider in the 90th percentile of 258 pulmonary disease providers in Indiana.

See all pulmonary disease providers in Indiana →

Medicare billing

Part B allowed, 2024
$367,681
Medicare patients
943
Services billed
4,169

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other pulmonary disease in Portage

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →